4xHRE-MinTK-CRE-ODD Citations (3)

Originally described in: Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis.
Godet I, Shin YJ, Ju JA, Ye IC, Wang G, Gilkes DM Nat Commun. 2019 Oct 24;10(1):4862. doi: 10.1038/s41467-019-12412-1. PubMed Journal

---

Articles Citing 4xHRE-MinTK-CRE-ODD

Articles
A persistent invasive phenotype in post-hypoxic tumor cells is revealed by fate mapping and computational modeling. Rocha HL, Godet I, Kurtoglu F, Metzcar J, Konstantinopoulos K, Bhoyar S, Gilkes DM, Macklin P. iScience. 2021 Aug 4;24(9):102935. doi: 10.1016/j.isci.2021.102935. eCollection 2021 Sep 24. PubMed
Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC. Godet I, Mamo M, Thurnheer A, Rosen DM, Gilkes DM. Cancers (Basel). 2021 Nov 2;13(21). pii: cancers13215509. doi: 10.3390/cancers13215509. PubMed
The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia. Bhatavdekar O, Godet I, Gilkes D, Sofou S. Pharmaceutics. 2022 Oct 13;14(10):2184. doi: 10.3390/pharmaceutics14102184. PubMed

If you have published an article using this material, please email us at to have your article added to this page.